FDA

Feb 01 2025HEALTH

Ending the Opioid Addictionwith New Journavx Drug

A new painkiller has been approved for sale. This medication, Journavx, is a step forward that skips those addictive opioids that many of us are familiar with. Think of it as a shortcut around the addiction crisis. This pain reliever tackles those intense, short-term pains from things like surgery,

reading time less than a minute
Feb 01 2025HEALTH

New Hope for Pain Relief: A Game Changer

Imagine living in a world where pain relief doesn't come with a risk of addiction. This is the idea that has been brought to life with a new FDA approved medicine. The last time a similar pill was approved was more than 20 years ago. The medicine is called Journavx, or suzetrigine. This pill is a

reading time less than a minute
Jan 31 2025HEALTH

Milk in Potato Chips: A Scary Surprise for Allergy Sufferers

Last year, the FDA in America announced a serious warning about some potato chips. The chips in question were Lay's Classic Potato Chips, which had a hidden ingredient: milk. This was dangerous news for people with severe milk allergies. Eating even one chip could trigger a deadly reaction. The FDA

reading time less than a minute
Jan 31 2025HEALTH

A New Hope In Pain Relief.

In a significant development, the U. S. Food and Drug Administration (FDA) has given the green light to a new non-opioid painkiller. Called Journavx. This new medicine is a big deal because it's the first of its kind to target pain signals in the peripheral nervous system. This means it stops pain b

reading time less than a minute
Jan 25 2025HEALTH

Unraveling Drug Approvals in Rare Diseases: A Decade in Review

Over the past decade, the Food and Drug Administration (FDA) in the U. S. has faced an uphill task when it comes to approving drugs for rare diseases. These diseases, often with small patient populations, come with unique challenges like varied genetic and symptom patterns. This makes it tough to fi

reading time less than a minute
Jan 25 2025POLITICS

Health Agencies Take a Break from Updates

Some federal health agencies have temporarily stopped sharing certain information, like updates on food outbreaks and flu vaccinations. This pause is part of a wider communication break ordered by the Trump administration. It gives the new team time to set up their own way of sharing important healt

reading time less than a minute
Jan 25 2025HEALTH

Beware of Autism Detox Treatments: Experts Warn of Risks

The internet is buzzing with claims about "autism detox treatments, " promising to remove heavy metals and reverse autism diagnoses. These products, often made with zeolite, are targeted at kids and come in forms like tinctures and sprays. The FDA isn't buying it—they warn that these treatments aren

reading time less than a minute
Jan 23 2025POLITICS

The Trump Administration Puts a Pause on Health Agency Communications

In an unexpected move, the Trump administration has hit the pause button on many health agency communications. This includes messages from big names like the CDC and the FDA. The command came down in a memo from the acting Secretary of Health and Human Services. Until at least the end of January, re

reading time less than a minute
Jan 22 2025HEALTH

Zyn Pouches: A New Way to Nicotine, Less Harmful Than Cigarettes

You might have heard of Zyn pouches – they’re like tiny bags filled with nicotine, but without the smoke. The FDA just said these are safer than cigarettes and can now be sold in the US. Philip Morris, the company behind Zyn, had to promise not to advertise to kids. Only about 1. 8% of teens use the

reading time less than a minute
Jan 16 2025HEALTH

Nicotine Pouches Get Green Light: A Safer Smoking Alternative?

Ever wondered if there could be a safer way to quit smoking? Well, the Food and Drug Administration (FDA) just gave a thumbs up to Philip Morris International’s Zyn nicotine pouches. These aren’t your typical tobacco products. They come in flavors like coffee, mint, and menthol, and they might help

reading time less than a minute